Search: WFRF:(Andersson Håkan 1944) >
Water-miscible toco...
Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis.
-
Soltani-Frisk, S (author)
-
- Gronowitz, Eva, 1956 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik,Institute for the Health of Women and Children, Dept of Paediatrics
-
- Andersson, Håkan, 1944 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för onkologi,Institute of Selected Clinical Sciences, Department of Oncology
-
show more...
-
- Strandvik, Birgitta, 1938 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik,Institute for the Health of Women and Children, Dept of Paediatrics
-
show less...
-
(creator_code:org_t)
- 2001
- 2001
- English.
-
In: Acta paediatrica (Oslo, Norway : 1992). - 0803-5253. ; 90:10, s. 1112-5
- Related links:
-
https://gup.ub.gu.se...
Abstract
Subject headings
Close
- Vitamin E deficiency is a major problem in cystic fibrosis. Modern pancreatic enzymes may improve the absorption of fat-soluble vitamins to make water dispersion less important. In order to compare the absorption of fat-soluble (F) and water-miscible (W) tocopheryl acetate, equivalent amounts (10 mg/kg body weight) were given to five patients with cystic fibrosis (CF) and five age- and sex-matched healthy controls. Serum was analysed for vitamin E using HPLC before and 1, 2, 3, 4, 6, 8, 10, 24 and 28 h after the oral intake. The median peak concentrations in the sera of controls were 41.9 micromol/L after F and 39.8 micromol/L after W preparations, corresponding values in CF patients being 21.3 and 26.8 micromol/L, and corresponding means +/- SD were 41.6+/-6.7 and 38.4+/-3.3, and 27.1+/-14.5 and 28.8+/-8.3, respectively. Although the area under the curve was lower for W than F preparations in both CF patients and controls, these differences were not significant. CONCLUSION: The results in our study are consistent with those of an earlier study using the same preparation and suggest that it is not necessary to use water-miscible preparation of alpha-tocopheryl acetate in CF patients receiving modern pancreatic enzyme supplementation.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Keyword
- Absorption
- Adjuvants
- Immunologic
- pharmacokinetics
- Adolescent
- Adult
- Antioxidants
- pharmacokinetics
- Cystic Fibrosis
- metabolism
- Fats
- Female
- Humans
- Male
- Middle Aged
- Pharmaceutical Preparations
- Solubility
- Tocopherols
- Vitamin E
- pharmacokinetics
- Water
- alpha-Tocopherol
- analogs & derivatives
- pharmacokinetics
Publication and Content Type
- vet (subject category)
- art (subject category)
Find in a library
To the university's database